24 related articles for article (PubMed ID: 7110964)
1. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G
Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of isosorbide dinitrate and its mononitrate metabolites after intravenous infusion.
Santoni Y; Iliadis A; Cano JP; Luccioni R; Frances Y
J Pharmacokinet Biopharm; 1986 Feb; 14(1):1-17. PubMed ID: 3746630
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions.
Schneider W; Menke G; Heidemann R; Satter P; Kaltenbach M; Rietbrock N
Eur J Clin Pharmacol; 1990; 38(2):145-7. PubMed ID: 2338111
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability and metabolism of isosorbide dinitrate from a transdermal spray.
Laufen H; Leitold M
Arzneimittelforschung; 1992 Jul; 42(7):931-5. PubMed ID: 1418058
[TBL] [Abstract][Full Text] [Related]
5. Effects of disease, route of administration, cigarette smoking, food intake on the pharmacokinetics and circulatory effects of isosorbide dinitrate.
Fung HL; Ruggirello D; Stone JA; Parker JO
Z Kardiol; 1983; 72 Suppl 3():5-10. PubMed ID: 6666234
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of isosorbide dinitrate after intravenous infusion in human subjects.
Taylor T; Chasseaud LF; Doyle E; Darragh A; O'Kelly DA; Fitzgerald D
Biopharm Drug Dispos; 1980; 1(3):149-56. PubMed ID: 7448342
[TBL] [Abstract][Full Text] [Related]
7. Fate of orally given isosorbide dinitrate in cirrhotic patients.
Bogaert MG; Rosseel MT; Elewaut A
Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):491-2. PubMed ID: 6500768
[TBL] [Abstract][Full Text] [Related]
8. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
Mahgoub AA; El-Medany AH; Abdulatif AS
Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics of isosorbide dinitrate administered by intravenous infusion to hypertensive patients (author's transl)].
Frydman A; Levenson J; Simon A; Safar M; Bieder A; Bertharion J; Gaillot J
Nouv Presse Med; 1982 Jun; 11(27):2049-56. PubMed ID: 7110964
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of organic nitrates.
Bogaert MG
Clin Pharmacokinet; 1983; 8(5):410-21. PubMed ID: 6414751
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
